Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Immune targeting of cancer stem cells in gastrointestinal oncologyImmunobiology of mesenchymal stem cellsMesenchymal Stem Cells Regulate the Innate and Adaptive Immune Responses Dampening Arthritis ProgressionAdipose tissue-derived mesenchymal stem cells increase skin allograft survival and inhibit Th-17 immune responseThe promising potential of menstrual stem cells for antenatal diagnosis and cell therapyInnate immune system and preeclampsia.How stem cells speak with host immune cells in inflammatory brain diseasesHuman adipose stromal cell therapy improves survival and reduces renal inflammation and capillary rarefaction in acute kidney injury.Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-α levelsMesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational ageEffect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.All-Trans Retinoic Acid Improves the Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Treatment of Ankylosing Spondylitis: An In Vitro StudyMesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic DiseasesInterleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses.Comparison of biological characteristics of mesenchymal stem cells derived from maternal-origin placenta and Wharton's jelly.Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats.Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant productionBiliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism.Role of mesenchymal stem cells in cell life and their signaling.Repairing effects of ICAM-1-expressing mesenchymal stem cells in mice with autoimmune thyroiditis.Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy.Increased Paracrine Immunomodulatory Potential of Mesenchymal Stromal Cells in Three-Dimensional CultureThe influence of macrophages on mesenchymal stromal cell therapy: passive or aggressive agents?Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors.Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.Mesenchymal stem cells moderate immune response of type 1 diabetes.Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets.Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.Mesenchymal Stem Cells Direct the Immunological Fate of Macrophages.Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance.Human Bone Marrow-Derived Mesenchymal Stromal Cells Differentially Inhibit Cytokine Production by Peripheral Blood Monocytes Subpopulations and Myeloid Dendritic Cells.TH17 predominant T-cell responses in radiation-induced bowel disease are modulated by treatment with adipose-derived mesenchymal stromal cells.Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.Protective effects of Fc-fused PD-L1 on two different animal models of colitis.
P2860
Q26746104-D5F0C376-D68E-4DF7-99F8-A5BE881F7F39Q26749015-74A99AFD-8EF8-4775-8ADA-2F9DD2BF64C8Q27004487-097558F4-97F8-45DC-AACD-9C4E905E128EQ28078360-B29277F0-CC36-491B-A2D1-2616FE9931F9Q28534075-227A46D3-853F-4FC8-9333-FAD2E1E13CE0Q33658078-8982738D-24F0-4013-BFA0-0923CBD406C4Q33658840-14D02A7A-3BE5-42CF-A70E-09CA2213E5C1Q33776557-BF52D32F-22AB-4780-B7EC-AFF3A5F3645DQ33844666-8C9580A4-D962-491E-8DB4-68618360A7F2Q34144015-B91471D5-D6B9-44CC-8D77-0283DC75ED08Q34259085-DE0DC449-41E0-42F6-8BDF-EAFFDC14E23AQ34751229-81FCA1C7-27FF-4D03-B328-0D5243A16BE4Q35562203-FA016807-2CCF-4552-A014-5B1E7224BC47Q35739571-4E9798C6-7011-4E89-BD50-8640A337BBA0Q35750457-FAD2678F-B2EB-4267-930A-542D174DE627Q36201380-2738937C-578D-46DD-99A6-5CB8D6F16BBFQ36321598-17BE0CC8-04E1-49BF-A86F-AC497A495831Q36700629-C7F6B3EA-F36F-4716-8DB7-9336D237EE09Q37020401-7474BB81-A8F3-42F1-8749-AFAD50A2A010Q37170068-83CA6DD7-77F4-4CBF-9478-F1F63F3A697DQ37176323-48F640C2-6E39-41FA-A134-271CA5164C7DQ37326277-59C63683-C25B-497C-89C1-253108AD34CFQ37350687-C2F200E7-714F-4CF2-9D3E-DA77B1C57B04Q37589437-33CE97CB-50E3-496E-8ACB-C29AB151B36AQ37734541-1D866EDD-C8C6-4CE5-9DEE-2A42144DDD15Q38186634-F196D801-DA3F-449B-8EF6-FF9A94A1DB34Q38217417-6D179698-B43A-4097-8493-3131A7385E2EQ38727840-049ED33A-E77A-4494-8E05-08A89181C747Q38767642-005C461C-C14A-451F-B54F-BAEA7D7FFFF9Q38794832-CA8272A6-D23B-462D-9D1F-50059658AE15Q38840236-B371608E-7CAC-4ECC-8539-27BB4A5B7A88Q38977465-4ABF249A-A6ED-4D62-9E15-9F3A581C73EAQ38998166-C71A6B78-C117-48E5-80B1-70E2908E184EQ39178437-99B7591A-952F-4B59-A433-DC39572872C2Q39271587-0E224330-139F-45E0-A237-157399D8B74EQ39430866-F273AF4C-08E1-49D8-A69D-28134D05D66EQ40548665-BB3B1059-01C5-48FA-865E-696B4822F2A9Q40733169-4072FB5D-D68C-439E-9BD9-7263D7BC6382Q41695046-59222DE1-B7DD-404A-92E6-4EA1223C17A1Q42214211-CC023B6B-75FF-42E9-9138-96AC27D14DB6
P2860
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
@ast
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
@en
type
label
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
@ast
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
@en
prefLabel
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
@ast
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
@en
P2093
P2860
P1433
P1476
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway
@en
P2093
Christian Jorgensen
Fernando Figueroa
Flavio Carrión
Maroun Khoury
Patricia Luz-Crawford
Ximena Fernandez
P2860
P304
P356
10.1371/JOURNAL.PONE.0045272
P407
P577
2012-09-17T00:00:00Z